Table 1 Clinical and echocardiographic characteristics of female patients with FD cardiomyopathy
|
Group 1 n = 4 |
Group 2 n = 9 |
Group 3 n = 8 |
Group 4 n = 3 | |
|---|---|---|---|---|
| Age | 38 ± 3 | 51.4 ± 6.7 | 60.3 ± 9.6 | 63.0 ± 5.6 |
| Cardiac symptoms | ||||
| Angina,% | 0 | 33 | 63 | 33 |
| Dyspnea,% | 0 | 67 | 87 | 100 |
| Palpitation, % | 100 | 100 | 100 | 100 |
| Ecocardiography | ||||
| Maximal wall thickness, mm | 9.03 ± 0.5 | 13.3 ± 1.5 | 17.1 ± 1.2 | 21.0 ± 1.7 |
| Left ventricular ejection fraction,% | 65 ± 7 | 66 ± 3 | 64 ± 3 | 62 ± 5 |
| E/A ratio | 1.2. ± 0.4 | 1. ± 0.4 | 0.9 ± 0.7 | 0.9 ± 0.3 |
| Morphometry | ||||
| Percent of non affected cardiomyocytes | 30.5 ± 4.2 | 32.4 ± 12.5 | 32.8 ± 9.6 | 32.7 ± 3.3 |
| Diameter of non affected cardiomyocytes, micron | 13.3 ± 3.3 | 21.0 ± 2.5 | 26.5 ± 2.5 | 33.7 ± 3.4 |
| Diameter of affected cells, micron | 26.2 ± 9.1 | 37.8 ± 18.6 | 43.3 ± 20.1 | 51.7 ± 14.9 |
| Percent area occupied by vacuoles | 56.6 ± 65.7 | 62.2 ± 69.5 | 65.2 ± 72.8 | 67.1 ± 58.9 |
| Fibrosis, % | 2.4 ± 5.7 | 8.3 ± 12.7 | 14.4 ± 19.0 | 17.0 ± 5.3 |
| Genetic |
c.680G > A, c.335G > A, c.668G < A |
c.680G > A, cN46delG, c.548G > G, c.666delC, c.901C > G, c.644A > G |
c.C835C > A, c668G < A, c547 + 1G > A, c.644A > G |
c.679C > T, c.335G > A, c.644A > G |